biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. The company is headquartered in Irving, Texas and currently employs 217 full-time employees. The company went IPO on 2021-03-02. The firm provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. The company also sells a complementary Biote-branded line of dietary supplements. The Biote Method’s proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.
Mr. Bret Christensen is the Chief Executive Officer of Biote Corp, joining the firm since 2025.
What is the price performance of BTMD stock?
The current price of BTMD is $2.21, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Biote Corp?
Biote Corp belongs to Pharmaceuticals industry and the sector is Health Care
What is Biote Corp market cap?
Biote Corp's current market cap is $86.8M
Is Biote Corp a buy, sell, or hold?
According to wall street analysts, 7 analysts have made analyst ratings for Biote Corp, including 3 strong buy, 6 buy, 2 hold, 0 sell, and 3 strong sell